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Abstract
The National Heart, Lung, and Blood Institute convened a Working Group in January 2015 to 
explore issues related to an integrated data network for congenital heart disease (CHD) research. 
The overall goal was to develop a common vision for how the rapidly increasing volumes of data 
captured across numerous sources can be managed, integrated, and analyzed to improve care and 
outcomes. This report summarizes the current landscape of CHD data, data integration 
methodologies used across other fields, key considerations for data integration models in CHD, 
and the short- and long-term vision and recommendations made by the Working Group.
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 Introduction
As medicine moves into the era of big data, it is important to develop a common vision for 
how the rapidly increasing volume of data will be managed, integrated, and analyzed to 
improve care and outcomes. This holds true across a variety of different disciplines and 
specialties, including the field of congenital heart disease (CHD). Only through coordinated 
efforts will the CHD community be able to fully leverage available and emerging data 
sources to support important investigations, and conduct research most efficiently. To 
facilitate this process, the National Heart, Lung, and Blood Institute (NHLBI) convened a 
Working Group meeting in January 2015 in Bethesda, MD, to explore issues related to CHD 
data integration. The goals of the Working Group were to develop a vision for an integrated 
data network to support CHD research and to identify critical elements as well as potential 
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barriers. The Working Group consisted of experts in pediatric and adult cardiology, 
cardiothoracic surgery, health services and outcomes research, epidemiology, informatics, 
and statistics.
 The Era of Big Data
The past several years have been characterized by what has been termed an era of “big 
data”1–3. During this time, the volume, velocity, and variety of data captured across 
numerous sources have increased exponentially, outpacing traditional techniques for 
managing and analyzing data. Newer data platforms, computing capabilities, and analytic 
techniques have been developed to better manage, integrate, analyze, and provide more 
“real-time” feedback to various industries regarding their data, with the goal of optimizing 
performance and outcomes1–3. For example, the automotive industry is capturing data 
generated by sensors on electric cars to better understand driving habits such as typical 
acceleration and braking patterns. These data are merged and analyzed with information on 
frequency of battery charging, and location of charging stations, to aid in better design of the 
next generation of vehicles and charging infrastructure1,4. In the hotel industry, certain 
chains merge and analyze weather and airline flight cancellation data, along with 
information on geographic location of their hotels. These data are used to target mobile ads 
to passengers likely stranded away from home and enable easy booking of nearby hotels5.
 Data in Medicine
Historically in medicine and in the hierarchy of medical research, the value of databases, 
registries, and other data sources in the cycle of scientific discovery has not always been 
recognized1,6. “Mining datasets” and “database research” have often been seen as lesser 
pursuits compared to basic science research or clinical trials. However, several developments 
have begun to change the way data in medicine are viewed. First, similar to other fields, the 
volume and granularity of data captured electronically in healthcare has increased 
exponentially in recent years, including data captured in the electronic health record (EHR), 
clinical registries, research datasets, monitoring systems, and other sources. With this has 
come the recognition that analyzing and integrating these datasets can expand the range of 
questions that can be answered1. For example, early results suggest integrating continuous 
data streams generated by various monitoring systems with clinical outcomes data may 
enable better prediction and treatment of adverse events in intensive care settings1,7. Second, 
along with this increase in availability of data, there has been a simultaneous decrease in 
funding to support biomedical research8. This has led to further interest in better 
understanding how to leverage available data to power research more efficiently; for 
example the use of existing registries as platforms to support clinical trials with the goal of 
reducing time and costs associated with data collection9. Finally, the current national 
emphasis in healthcare on improving quality and optimizing healthcare value has 
necessitated analyzing and integrating healthcare quality and cost data across a variety of 
sources in order to understand the landscape of care delivery and outcomes, to investigate 
relationships between quality and cost, and to develop strategies for improvement10. These 
and other recent trends have led to a greater recognition in medicine of the value of 
leveraging the increasing volume of available data. As further evidence of this, the National 
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Institutes of Health recently launched the Big Data to Knowledge and Precision Medicine 
Initiatives11,12. Both of these programs involve efforts to integrate information across a 
variety of sources to conduct research more efficiently and improve care.
 Current Landscape of CHD Data
 Data sources, infrastructure, and collaboration
The current CHD data environment has many assets (Table 1). Numerous existing clinical 
registries, administrative/billing databases, public health surveillance databases, research 
datasets, and other sources contain a wealth of important information that can be used to 
facilitate research, surveillance, and quality improvement activities in the field13. In 
addition, data are being increasingly captured via a variety of newer modalities including the 
EHR, data generated from medical monitors and devices, and genetic and biomarker data. 
Some centers are also beginning to capture longer-term outcomes data such as quality of life 
and neurodevelopmental outcomes as described in more detail in subsequent sections. Most 
congenital heart programs across the US have existing local infrastructure to support data 
collection for various registries and other datasets, and infrastructure to integrate data across 
centers also exists as a part of several national registries, multi-center quality improvement 
activities, and research efforts13. Finally, there is an environment of collaboration among 
investigators and many congenital heart programs related to participation in these efforts, 
including the Pediatric Heart Network, National Pediatric Cardiology Quality Improvement 
Collaborative, and Pediatric Cardiac Critical Care Consortium, among many others14–17. 
Annual meetings of the Multi-societal Database Committee for Pediatric and Congenital 
Heart Disease further aid in facilitating sharing of ideas and collaboration across different 
registries and databases18.
 Standardized nomenclature
Another particularly important aspect of the CHD data landscape (Table 1) has been the 
major effort over the past two decades to develop a standardized nomenclature system19. In 
the 1990s both The European Association for Cardio-Thoracic Surgery (EACTS) and The 
Society of Thoracic Surgeons (STS) created databases to assess congenital heart surgery 
outcomes, and established the International Congenital Heart Surgery Nomenclature and 
Database Project. By 2000, a common nomenclature and common core minimal dataset 
were adopted by both the EACTS and STS Congenital Heart Surgery Databases. 
Subsequently, the International Society for Nomenclature of Pediatric and Congenital Heart 
Disease was formed, and its Nomenclature Working Group cross-mapped the nomenclature 
developed by the EACTS and STS with the European Pediatric Cardiac Code of the 
Association for European Pediatric Cardiology, thereby creating the International Pediatric 
and Congenital Cardiac Code (IPCCC), which is available for free download at [http://
www.IPCCC.NET]19. The IPCCC is currently used by multiple databases that span the 
spectrum of pediatric and congenital cardiac care including:
• Cardiac surgery (STS Congenital Heart Surgery Database, EACTS Congenital 
Heart Surgery Database, Japan Congenital Cardiovascular Surgery Database 
[JCCVSD], United Kingdom Central Cardiac Audit Registry [UKCCAD])
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• Cardiology (The IMPACT RegistryTM [IMproving Pediatric and Adult 
Congenital Treatment] of the National Cardiovascular Data RegistryR of The 
American College of Cardiology)
• Anesthesia (The Joint Congenital Cardiac Anesthesia Society [CCAS]–STS 
Congenital Cardiac Anesthesia Database)
• Critical care (The Pediatric Cardiac Critical Care Consortium [PC4] and The 
Virtual Pediatric Intensive Care Unit System [VPS])
 Data integration efforts to date
A final strength of the current CHD data environment is the development and 
implementation of methods over the past several years to support integration and linkages 
between various CHD data sources1,13 (Table 1, 2). These methods have capitalized on the 
strengths and mitigated the weaknesses of different types of datasets, and have enabled 
research that would have otherwise not been possible with individual datasets alone. In 
addition, methods to facilitate sharing and integration of data have also begun to support the 
use of existing data (e.g. clinical registry data) to power studies more efficiently.
 Linking on Unique Identifiers—Local medical records, and some larger datasets, 
contain unique identifiers such as medical record number or social security number that can 
facilitate linkage with other datasets1,13,20,21 (Table 2). For example, using these methods 
investigators have previously linked data from outpatient pediatric cardiology visits for chest 
pain to the National Death Index and Social Security Death Master File to evaluate for 
subsequent mortality in this cohort21. However, new limitations on the availability of the 
Social Security Death Master File for research purposes may pose a greater challenge to the 
use of this dataset in the future.
 Linking on Indirect Identifiers—While linkages based on direct or unique identifiers 
are the easiest way to merge datasets, these identifiers are often not collected in many 
databases due to a variety of regulatory requirements and privacy concerns, and may only be 
available at the local level. Thus, methodology has also been developed to link database 
records through the use of “indirect” identifiers1,13,22,23 (Table 2). These include variables 
such as date of birth, date of admission, date of discharge, sex, and center where 
hospitalized. It has been shown that nearly all records at a given congenital heart center can 
be uniquely identified using a combination of these indirect identifiers, and that a crosswalk 
can then be created between two datasets, linking patients on the values of center where 
hospitalized and the indirect identifiers23.
This methodology has been utilized in the pediatric cardiovascular population to merge 
information from a large clinical registry (The STS Congenital Heart Surgery Database) 
with a pediatric administrative dataset (Pediatric Health Information System 
Database)1,13,23–26. Linking these two datasets allows utilization of the detailed operative 
and outcomes data from the clinical registry, and the resource utilization data from the 
administrative dataset. The current linked dataset includes records from >60,000 children 
undergoing congenital heart surgery at 33 different hospitals from 2004–2010, with 
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expansion and updating of the dataset underway. Several comparative effectiveness studies 
and analyses of healthcare costs have been successfully conducted with this dataset, 
leveraging variables from both data sources to facilitate analyses not otherwise possible with 
either dataset independently24–26. Similar methodology has also been used to merge clinical 
trial data from the Pediatric Heart Network Single Ventricle Reconstruction Trial with data 
from Children’s Hospital Association Case Mix dataset in order to perform integrated 
analyses of clinical outcomes and costs27.
Combinations of indirect and direct identifier linkage methodologies have also been utilized. 
For example, datasets may use indirect methods to link to a common dataset, and then use 
the common dataset to identify unique individuals. Using these methods, surveillance data 
from the Metropolitan Atlanta Congenital Defects Program was indirectly linked to vital 
records, as was data from the Special Education Database of Metropolitan Atlanta. Then 
deterministic (direct) linkage was done between the two datasets to evaluate the use of 
special education services among children with CHD28.
 Center-level Linkages—Linking registry data to other independently collected center-
level data through matching on center can be easily accomplished (Table 2). For example, 
independently collected survey data regarding intensive care unit care models and nursing 
education and staffing levels have been successfully linked to The STS Congenital Heart 
Surgery Database1,13,29. These linkages enable evaluation of the variables collected in the 
survey in relation to outcomes data collected in the registry.
 Collaboration/Partnering Between Databases—Data can also be shared or 
integrated through collaboration and partnering between different organizations and datasets 
(Table 2). These methods can also reduce data entry burden at local sites. For example, the 
STS and the CCAS recently collaborated to add an anesthesia section to the surgical data 
collection forms1,13,30. Anesthesia data are now collected, harvested, reported, and analyzed 
at a central data coordinating center along with surgical data for participating centers. This 
approach is likely more time and cost efficient than creating a separate anesthesia database 
in which many of the fields regarding patient characteristics and the operative procedure 
would have been duplicated. Related efforts are underway to incorporate electrophysiology 
data within the IMPACT Registry31. An alternative method involves a more distributed 
approach with sharing of data definitions and variables between datasets and organizations, 
information technology solutions allowing single entry of data at the local level, and 
subsequent submission and distribution of both shared and unique data variables to 
applicable national datasets and data coordinating centers. An example of this is the shared 
IPCCC data definitions for certain variables between the STS, PC4, and IMPACT 
registries1,13,15,16,31.
 Supplementary Data Modules—Methods have also been developed to create data 
modules enabling efficient collection of supplemental data points to the primary data source 
(Table 2). The modules are generally web-based and can be quickly created and deployed to 
allow “real-time” collection of additional data needed to answer important research 
questions that may arise. This methodology has been recently successfully used by PC4 to 
collect supplemental data to the main registry to study the relationship between Vasoactive-
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Inotropic Score and outcome after infant cardiac surgery1,13,32. A module allowing for 
capture of additional data related to inotrope use was created, deployed, and linked to the 
main registry data for each patient. This facilitated efficient data collection with 391 infants 
prospectively enrolled across 4 centers in just 5 months32.
 Powering Clinical Trials Through Registries—In recent years it has become 
increasingly recognized that many variables of interest for prospective investigation, 
including clinical trials, are already being captured within clinical registries across an 
engaged group of sites on a routine basis1,9,13. It has been proposed that leveraging these 
existing registry data (and linkage with modules containing additional study-specific data 
when necessary) may be a more efficient way to power research, avoiding duplicate data 
collection and minimizing study start-up timelines. To date these methods have been used to 
facilitate two clinical trials in adult cardiovascular medicine – the SAFE-PCI (Study of 
Access Site for Enhancement of PCI for Women) and TASTE (Thrombus Aspiration during 
ST-Segment Elevation Myocardial Infarction) trials, both of which leveraged existing 
information in two different cardiac catheterization registries33,34. In the CHD community, 
work is currently underway within the Pediatric Heart Network to assess the completeness 
and accuracy of site’s local clinical registry data, and determine whether prospective studies 
and clinical trials may leverage these data to minimize duplicate data collection and promote 
greater efficiency.
 Current CHD data limitations
While a great deal of progress has been made over the past several years to better integrate 
and leverage available CHD data sources to more efficiently conduct research, many 
limitations remain1,13 (Table 1). As described in the preceding sections, most current 
methods to integrate data have involved 1:1 linkages of a certain dataset to another to answer 
a specific question. Regulatory and contracting issues have generally prevented use of these 
integrated datasets to answer additional research questions after the primary study is 
completed. More broad and comprehensive strategies for data integration across numerous 
sources are lacking, and the landscape still consists primarily of individual data silos. There 
is relatively limited capability from an information technology perspective to broadly share 
information across datasets, and data governance and collaboration models have yet to be 
developed across congenital heart centers and national organizations to facilitate such data 
sharing. Methodology to allow the use of existing data for more efficient prospective studies 
and clinical trials is just beginning to be developed in the field. Issues regarding consent and 
confidentiality will also require further evaluation. Finally, important longitudinal outcomes 
information is lacking, and simply linking existing datasets together will not address this 
issue.
 Data integration models across other fields
Several models supporting more comprehensive data integration exist across other fields, 
and may be useful examples for the CHD community to consider.
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 National Institute of Mental Health (NIMH) and National Database of Autism Research
In order to link information across studies enrolling patients with autism, the NIMH uses a 
global unique identifier (GUID)1,35,36. The GUID is a unique code generated in a manner to 
protect confidentiality. In order to generate a GUID, a combination of patient identifying 
information (typically name at birth, gender, city of birth, and date of birth) is entered into a 
software program at the local site35,36. Through one-way encryption, these elements are 
translated into hash codes, which cannot be traced back to the patient. The hash codes are 
then sent to a central data server which generates a GUID. The GUID is returned to the site 
where it is entered into the dataset for that patient. The GUID protects privacy in two ways – 
the identifiable information never leaves the local site, and the GUID cannot be traced back 
to the patient. Another important feature of the GUID is that the patient or family does not 
need to remember it. Patients and families only need to remember the individual data 
elements described above, and from these the same GUID is generated each time, regardless 
of location or timing of enrollment in a study. Thus, the GUID functions to uniquely identify 
the patient, is composed of information easily known to the patient that is invariant over a 
lifetime, and maintains patient privacy35,36. GUID’s are currently being piloted in the field 
of CHD for patients enrolled in studies conducted by the Pediatric Cardiac Genomic 
Consortium.
 PEDSnet
PEDSnet, funded by the Patient Centered Outcomes Research Institute (PCORI), is a 
clinical data research network consisting of eight of the nation’s largest pediatric academic 
medical centers, two existing pediatric consortia/quality improvement collaboratives, and 
two national data partners (Express Scripts, a national pharmacy benefits management 
company; and IMS Health, a data aggregator of multi-payor claims data)37,38. The goal of 
PEDSnet is to create a learning health system that integrates research into routine care 
settings, supports structured data capture, and quality improvement processes to rapidly 
implement advances in new knowledge37,38. To date, PEDSnet has harmonized data from 
4.5 million patients captured across member site’s EHR systems using a common 
terminology, and uses open source software to support data submission and aggregation. 
Analyses are primarily done at a centralized data coordinating center, although distributed 
queries across sites may also be possible (as discussed in further detail in subsequent 
sections) for certain research questions37,38.
 The Cardiovascular Research Network (CVRN)
The CVRN consists of 15 geographically distributed health care delivery systems caring for 
>10 million members that was established through initial funding by NHLBI to conduct 
large-scale adult cardiovascular research more efficiently, including epidemiologic studies, 
outcomes research, comparative effectiveness studies, and clinical trials39. Within the 
CVRN, data captured through each health care system’s EHR and multiple other electronic 
databases are linked at the site level using medical record numbers39. These data include 
clinical and resource utilization data across inpatient, emergency department, and outpatient 
settings, procedures, diagnoses, inpatient and outpatient pharmacy data, and laboratory test 
results. Data capture and architecture are standardized across each site’s Virtual Data 
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Warehouse using common data elements, naming conventions, and definitions to facilitate 
combining information in aggregate analyses39. Recent CVRN efforts within the CHD 
population have involved developing natural language text processing algorithms to attempt 
to identify patients with CHD from unstructured EHR data across multiple health systems40.
 Mini-Sentinel Program of the US Food and Drug Administration (FDA)
The goal of this program is to facilitate active surveillance and monitoring of the safety of 
medical products across the US. Mini-Sentinel uses a distributed data approach where 
participating data partners maintain physical and operational control over their own data41. 
A common data model was designed to meet the needs of the program, and each 
participating organization developed a process to extract, transform, and load its source data, 
applying the common data model, in order to create the distributed database. These data are 
then analyzed using programs developed centrally and executed locally by participating 
organizations41.
 Potential data integration models in CHD
There are several different integration models that may be considered to support CHD 
research which build on the existing models used across other fields. Two specific models 
that have received the most attention to date, and their strengths and weaknesses given the 
needs of the CHD community are discussed below.
 Creation of a CHD GUID and data linkages at the national level
One option to support data integration in CHD may build on the work done by the autism 
research community described in the preceding sections1,35,36. This could involve creation 
of a CHD GUID and collaboration among researchers, professional societies, and other 
groups to share and merge datasets containing these identifiers at the national level1. 
Potential advantages of this approach include its previous success within the autism research 
community, the ability for multiple linkages, and ability to maintain privacy in that direct 
identifiers are not sent outside of local sites. However, there are also certain disadvantages to 
consider. Some of the data elements needed to generate a GUID in its current form are not 
necessarily found in the medical record and require direct patient contact each time a GUID 
is generated – for example the data element of “city of birth”35,36. While this may be 
feasible for certain research studies, there would be several difficulties to consider within the 
current data collection infrastructure of most large registries and datasets where there 
generally is not direct patient interaction to capture data elements, such that additional local 
personnel and/or modification of data collection work flow would be required. There may 
also be issues to consider regarding consent. In addition, in order to enable linkages, the 
GUID must not only be generated and incorporated into individual datasets, but professional 
societies and other organizations must also agree to collaborate and share their datasets for 
linkage and analysis. Negotiating the various data sharing and governance policies of 
multiple professional societies and different organizations, who often have a focus primarily 
on adult cardiology and cardiac surgery, and current policies in some cases prohibiting 
sharing of data outside of central data coordinating centers, may prove to be challenging.
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 Supporting local linkages and a distributed data network model
An alternative option involves building on the experience of the CVRN, PEDSnet, and the 
Mini-Sentinel program described in the preceding sections to support data linkages at the 
local level, and sharing of these integrated data across heart centers, creating a distributed 
data network in CHD1. Local data linkages are feasible because most often research and 
registry data also reside locally at each participant site’s institution in addition to being 
aggregated into larger multicenter datasets. Local linkages are relatively easy to perform as 
direct or unique identifiers are readily available in these datasets as well as in the EHR. 
Merged local datasets can then be de-identified, and groups of institutions or heart centers 
can collaborate to share and aggregate information at a central site for analysis1. 
Alternatively, data may be kept at each site and standard algorithms developed to query and 
analyze the data locally, with results aggregated and combined across sites, similar to the 
Mini-Sentinel approach41. This model addresses some of the limitations identified with the 
use of GUID, and makes linked information available for both local purposes as well as for 
aggregate research. Data linkages within congenital heart center data warehouses are already 
taking place at several centers. For example, at one center participating in the Working 
Group, local data linkages have supported improved accuracy in determining surgical site 
infection rates (through merging infection data with CHD clinical registry data), which has 
in turn aided in efforts to reduce these infections42. Further, as discussed in previous 
sections, sharing data across heart centers for multi-center research is already a common 
practice, and this methodology could leverage these existing collaborative relationships.
 Additional considerations
In addition to strategies for integrating existing data, there are several other related areas of 
consideration. As described in previous sections, data regarding longer-term outcomes 
remain very limited, and efforts to promote efficient collection of these data have just 
recently begun1. Preliminary work suggests that engaging with patients and families directly 
can allow for the successful capture of critical longitudinal outcomes data such as survival, 
re-hospitalizations (particularly those that occur at institutions other than the surgical 
center), and important aspects of quality of life and burden of disease. For example, 
standardized patient-reported outcomes data have been successfully captured across two 
heart centers participating in the Working Group on >2000 patients to date. Methods are 
being developed to further the use of web-portals, mobile technology, and social media to 
allow for more efficient and wide-spread capture of patient-reported data43,44. In addition, 
the Cardiac Neurodevelopmental Outcomes Consortium is also working toward develop 
methods to capture standardized information obtained during neurodevelopment follow-up 
clinic visits. It will be important to incorporate these emerging longer-term outcomes data 
into the overall strategy developed for data integration.
A second area of consideration relates to the EHR. It has been hypothesized that leveraging 
EHR data can allow for improved efficiency and reduce data collection burden for various 
registries or research datasets. However these efforts will require additional work to improve 
the quality and standardization of data currently contained in the EHR1. While certain types 
of structured data may be efficiently captured through the EHR (e.g. lab values, 
medications), other data critical to CHD research may be more difficult to capture due to the 
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lack of granularity in the EHR and associated coding schemes (e.g. detailed information 
regarding anatomic diagnoses and procedures) and the lack of standardized definitions (e.g. 
for pre-operative comorbidities or post-operative complications).
Finally, with the expansion in the number and types of datasets and opportunities for 
linkages, it remains important to consider several key factors regarding data collection and 
analyses in general to ensure that research conducted using these datasets is meaningful1. 
These include issues related to accuracy and completeness of data, standardization (or lack 
thereof) of data elements and definitions, and the availability of variables within the dataset 
to perform appropriate risk adjustment or adjustment for differences in case mix across 
hospitals1. The availability and use of linked or integrated data sources does not lessen the 
importance of these critical factors.
 Short and Long-term Vision and Recommendations
The Working Group outlined a vision for how data might be integrated in the CHD 
community and developed several recommendations to achieve that vision over the short and 
long-term.
 Future vision
The Working Group acknowledged that our current conceptualization of data and data 
management is largely outdated. In addition, the volume and granularity of available data 
will continue to increase through more wide-spread capture of genomic and biomarker data, 
and real-time physiologic data, for example. Our current databases, data structure, and 
analytics will be insufficient for the task of managing and understanding these data. The 
Working Group recommended that further collaboration and consultation with data scientists 
and experts from diverse fields and industries outside of medicine will be important in 
understanding and incorporating modern data storage, manipulation, and analytic techniques 
into short and long term data solutions for the CHD community. For example, 3-D graphing 
techniques of large volumes of data have been shown recently in other industries to identify 
patterns that would otherwise not be apparent; however, these and other novel techniques 
have had limited application in medical research to date45. The importance of considering 
these techniques within the context of medical decision making was also discussed, as 
simple associations found in the data do not necessarily indicate cause and effect, and 
ensuring accuracy, reliability, and integrity of the data will continue to be important concepts 
regardless of the data storage and integration techniques used.
 Short-term goals
The Working Group recommended that the CHD community take steps in the near term to 
facilitate more comprehensive integration of information across currently available CHD 
data sources. The group felt that this could support further research that could not be 
conducted with individual datasets alone, and could also help to promote efficiency in 
research. The group recommended that of the data integration strategies discussed in 
previous sections, methodology supporting local data linkages and a distributed data 
network across collaborating sites seemed to meet more of the needs of the CHD community 
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compared with alternative approaches. The group acknowledged work in this area already 
taking place across several congenital heart center data warehouses as described in previous 
sections.
The Working Group recommended further efforts toward developing such a data network in 
CHD through engaging interested sites, developing a common data model, strategies for 
integration, and data governance policies, identifying potential funding sources, and 
conducting pilot studies to better understand the value of data integration and demonstrate 
proof of concept. The Working Group also recognized the lack of important longitudinal 
outcomes data in the field, and acknowledged that this issue cannot be addressed with 
linkages of current data sources alone. Further development and testing of strategies to 
support efficient capture of longer-term outcomes data that may be merged with existing 
data was recommended and the Working Group recognized ongoing efforts in this area 
described in the preceding sections. Exploring potential funding for data integration efforts 
was also recommended including funding through the Pediatric Heart Network, other 
NHLBI funding opportunities, PCORI, and foundation and philanthropic opportunities.
 Data standardization
The Working Group acknowledged the importance of data standardization to facilitate data 
pooling and analysis, and to decrease data entry burden at sites. The Working Group 
recognized the IPCCC as the standard nomenclature within the field, and recommended that 
IPCCC terminology and definitions should be incorporated into all relevant data sources 
when possible, including CHD registries, clinical data and the EHR, and research datasets, 
and recognized ongoing work to incorporate IPCCC terms into the International 
Classification of Diseases coding system. The Working Group recommended that consensus 
across sites and other stakeholders should be developed in order to standardize data 
collection in other areas as well, such as the collection of longitudinal follow-up 
information, neurodevelopmental outcomes, etc. and recognized recent work in this area by 
the Cardiac Neurodevelopmental Outcomes Consortium and others as described in the 
preceding sections.
 Align goals with stakeholder interests
Moving toward more fully integrated data systems will require engagement with multiple 
stakeholders, including hospital systems, researchers, national organizations and 
professional societies, and patients and families. To make a case for change, the field will 
need to discuss and identify the value of data integration from the perspectives of multiple 
stakeholders. At the hospital level, one such value point is the optimization of strategic 
investments already made in the EHR and clinical registries. Data integration will provide a 
more complete picture of the care provided and thus may enable improved quality, reduction 
in errors, and increased value. Patients and families are also critical stakeholders, and it will 
be important for data integration activities to seek to align with their interests, which may 
include improving care and outcomes, participating in longitudinal patient-reported data 
collection activities, and engaging in the process of determining quality improvement and 
research priorities.
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Several concurrent trends have provided the opportunity to re-calibrate our approach to data 
collection, integration, and analytics in biomedical research. In the CHD community, several 
advances in recent years including nomenclature standardization, development of rich 
clinical datasets, an environment of multi-center collaboration, and implementation of 
several data integration techniques, have provided a strong foundation for future work. There 
is now a need for further integration and collaboration in order to meet present and future 
challenges, and develop a more efficient and comprehensive research enterprise to improve 
the care and outcomes of patients with CHD.
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Table 1
Strengths and weaknesses of the current CHD data environment.
Strengths Weaknesses
Numerous data sources Data silos
Existing local infrastructure Lack of comprehensive data integration
Multi-institutional collaboration
Standardized nomenclature
Lack of a collaborative data governance model
Application of many data linkage techniques Limited infrastructure to support wide scale data integration and analysisLimited longer-term outcomes data
CHD = congenital heart disease
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Table 2
CHD data integration activities to date.
Method Examples of linked data
Linking on unique identifiers clinical data + survival data
Linking on indirect identifiers registry + administrative/cost data
clinical trial + administrative/cost data
Center-level linkages hospital survey data + registry data
Collaboration/partnering between databases registries with shared platforms, variables, definitions
Supplementary data modules to main registry registry data + research modules
CHD = congenital heart disease
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